Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
19515-6 Levomethamphetamine cutoff MCnc Urine Pt Qn Confirm   ACTIVE Levomethamphetamine cutoff [Mass/volume] in Urine for Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19515-6   Confirm     Observation       0 L-methamphet CtO Ur Cfm-mCnc       Y   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Levo-methamphetamine; L-methamphet; L-methamphetamine; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.44 1.0l               ng/mL       0
19516-4 Levorphanol PrThr Urine Pt Ord Screen   ACTIVE Levorphanol [Presence] in Urine by Screen method   MIN DefinitionDescription                   DRUG/TOX   19516-4   Screen     Both       0 Levorphanol Ur Ql Scn           Addiction; Dromoran; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Levo-dromoran; Levorphan; Methorphinan; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn 2.56 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19518-0 Levorphanol cutoff MCnc Urine Pt Qn Screen   ACTIVE Levorphanol cutoff [Mass/volume] in Urine for Screen method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19518-0   Screen     Observation       0 Levorphanol CtO Ur Scn-mCnc       Y   CtO; Dromoran; DRUG/TOXICOLOGY; Drugs; Level; Levo-dromoran; Levorphan; Mass concentration; Methorphinan; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn 2.44 1.0l               ng/mL       0
19519-8 Levorphanol cutoff MCnc Urine Pt Qn Confirm   ACTIVE Levorphanol cutoff [Mass/volume] in Urine for Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19519-8   Confirm     Observation       0 Levorphanol CtO Ur Cfm-mCnc       Y   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; Dromoran; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Levo-dromoran; Levorphan; Mass concentration; Methorphinan; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.44 1.0l               ng/mL       0
1952-1 Beta-2-Microglobulin MCnc Ser/Plas Pt Qn     ACTIVE Beta-2-Microglobulin [Mass/volume] in Serum or Plasma   MIN DefinitionDescription     mg/L;mcg/mL; ng/mL             CHEM   1952-1         Both       0 B2 Microglob SerPl-mCnc       Y   B; B2 Microglob; b2-M; Chemistry; Hematology; Heme; II; Level; Mass concentration; Microglob; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders 2.73 1               mg/L;ug/mL       293
19520-6 LORazepam PrThr Urine Pt Ord Screen   ACTIVE LORazepam [Presence] in Urine by Screen method   MIN DefinitionDescription                   DRUG/TOX   19520-6   Screen     Both       0 LORazepam Ur Ql Scn           Addiction; Ativan; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn 2.56 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19522-2 LORazepam cutoff MCnc Urine Pt Qn Screen   ACTIVE LORazepam cutoff [Mass/volume] in Urine for Screen method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19522-2   Screen     Observation       0 LORazepam CtO Ur Scn-mCnc       Y   Ativan; CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn 2.44 1.0l               ng/mL       0
19523-0 LORazepam cutoff MCnc Urine Pt Qn Confirm   ACTIVE LORazepam cutoff [Mass/volume] in Urine for Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19523-0   Confirm     Observation       0 LORazepam CtO Ur Cfm-mCnc       Y   Ativan; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.73 1.0l               ng/mL       0
19524-8 Lormetazepam PrThr Urine Pt Ord Screen   ACTIVE Lormetazepam [Presence] in Urine by Screen method   MIN DefinitionDescription                   DRUG/TOX   19524-8   Screen     Both       0 Lormetazepam Ur Ql Scn           DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn 2.56 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19525-5 Lormetazepam PrThr Urine Pt Ord Confirm   ACTIVE Lormetazepam [Presence] in Urine by Confirmatory method   MIN DefinitionDescription                   DRUG/TOX   19525-5   Confirm     Both       0 Lormetazepam Ur Ql Cfm           Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn 2.56 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19526-3 Lormetazepam cutoff MCnc Urine Pt Qn Screen   ACTIVE Lormetazepam cutoff [Mass/volume] in Urine for Screen method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19526-3   Screen     Observation       0 Lormetazepam CtO Ur Scn-mCnc       Y   CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn 2.44 1.0l               ng/mL       0
19527-1 Lormetazepam cutoff MCnc Urine Pt Qn Confirm   ACTIVE Lormetazepam cutoff [Mass/volume] in Urine for Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19527-1   Confirm     Observation       0 Lormetazepam CtO Ur Cfm-mCnc       Y   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.44 1.0l               ng/mL       0
19528-9 Lysergate diethylamide PrThr Urine Pt Ord Screen   ACTIVE Lysergate diethylamide [Presence] in Urine by Screen method   MIN DefinitionDescription                   DRUG/TOX   19528-9   Screen     Both       0 LSD Ur Ql Scn           Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; LSD; Lysergic acid; Lysergic acid diethylamide; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn 2.73 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
1953-9 Beta-2-Microglobulin MCnc Urine Pt Qn     ACTIVE Beta-2-Microglobulin [Mass/volume] in Urine   MIN DefinitionDescription     mg/L;mcg/mL; ng/mL             CHEM   1953-9         Both       0 B2 Microglob Ur-mCnc       Y   B; B2 Microglob; b2-M; Chemistry; Hematology; Heme; II; Level; Mass concentration; Microglob; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.73 1               ug/L;ng/mL       0
19530-5 Lysergate diethylamide cutoff MCnc Urine Pt Qn Screen   ACTIVE Lysergate diethylamide cutoff [Mass/volume] in Urine for Screen method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19530-5   Screen     Observation       0 LSD CtO Ur Scn-mCnc       Y   CtO; DRUG/TOXICOLOGY; Drugs; Level; LSD; Lysergic acid; Lysergic acid diethylamide; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn 2.34 1.0l               ng/mL       0
19531-3 Lysergate diethylamide cutoff MCnc Urine Pt Qn Confirm   ACTIVE Lysergate diethylamide cutoff [Mass/volume] in Urine for Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19531-3   Confirm     Observation       0 LSD CtO Ur Cfm-mCnc       Y   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; LSD; Lysergic acid; Lysergic acid diethylamide; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.36 1.0l               ng/mL       0
19532-1 Meperidine PrThr Urine Pt Ord Screen   ACTIVE Meperidine [Presence] in Urine by Screen method   MIN DefinitionDescription                   DRUG/TOX   19532-1   Screen     Both       0 Meperidine Ur Ql Scn           Addiction; Algil; Alodan; Centralgine; Demerol; Dispadol; Dolantin; Dolosal; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Pethidine; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn 2.73 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19534-7 Meperidine cutoff MCnc Urine Pt Qn Screen   ACTIVE Meperidine cutoff [Mass/volume] in Urine for Screen method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19534-7   Screen     Observation       0 Meperidine CtO Ur Scn-mCnc       Y   Algil; Alodan; Centralgine; CtO; Demerol; Dispadol; Dolantin; Dolosal; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pethidine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn 2.73 1.0l               ng/mL       0
19535-4 Meperidine cutoff MCnc Urine Pt Qn Confirm   ACTIVE Meperidine cutoff [Mass/volume] in Urine for Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19535-4   Confirm     Observation       0 Meperidine CtO Ur Cfm-mCnc       Y   Algil; Alodan; Centralgine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; Demerol; Dispadol; Dolantin; Dolosal; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Pethidine; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.44 1.0l               ng/mL       0
19536-2 Mephobarbital PrThr Urine Pt Ord Screen   ACTIVE Mephobarbital [Presence] in Urine by Screen method   MIN DefinitionDescription                   DRUG/TOX   19536-2   Screen     Both       0 Mephobarbital Ur Ql Scn           Barbiturate; DRUG/TOXICOLOGY; Drugs; Mebaral; Methylphenobarbital; Ordinal; Phenitone; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn 2.56 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19537-0 Mephobarbital PrThr Urine Pt Ord Confirm   ACTIVE Mephobarbital [Presence] in Urine by Confirmatory method   MIN DefinitionDescription                   DRUG/TOX   19537-0   Confirm     Both       0 Mephobarbital Ur Ql Cfm           Barbiturate; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Mebaral; Methylphenobarbital; Ordinal; Phenitone; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn 2.73 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19539-6 Mephobarbital MCnc Urine Pt Qn     ACTIVE Mephobarbital [Mass/volume] in Urine   MIN DefinitionDescription     ug/mL             DRUG/TOX   19539-6         Both       0 Mephobarbital Ur-mCnc       Y   Barbiturate; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Mebaral; Methylphenobarbital; Phenitone; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.42 1.0l               ug/mL       0
1954-7 Beta-N-acetylhexosaminidase CCnc Ser/Plas Pt Qn     ACTIVE Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Serum or Plasma   MIN DefinitionDescription     nmol/hr/mL;nmol/mL/H; units/L             CHEM   1954-7         Both       0 B-NAH SerPl-cCnc       Y   B; B-NAH; Catalytic Concentration; Chemistry; GM2-gangliosidosis; Hex A; Hex B; HEXA; Hexosaminidase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Sandhoff disease; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tay Sachs Disease 2.73 1               nmol/h/mL     Updated System from Ser to Ser/Plas since this test can be performed on serum or plasma. 0
19540-4 Mephobarbital cutoff MCnc Urine Pt Qn Screen   ACTIVE Mephobarbital cutoff [Mass/volume] in Urine for Screen method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19540-4   Screen     Observation       0 Mephobarbital CtO Ur Scn-mCnc       Y   Barbiturate; CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Mebaral; Methylphenobarbital; Phenitone; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn 2.73 1.0l               ng/mL       0
19541-2 Mephobarbital cutoff MCnc Urine Pt Qn Confirm   ACTIVE Mephobarbital cutoff [Mass/volume] in Urine for Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19541-2   Confirm     Observation       0 Mephobarbital CtO Ur Cfm-mCnc       Y   Barbiturate; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Mebaral; Methylphenobarbital; Phenitone; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.44 1.0l               ng/mL       0
104,672 results found